Literature DB >> 36171289

Bespoke library docking for 5-HT2A receptor agonists with antidepressant activity.

Anat Levit Kaplan1, Danielle N Confair2, Kuglae Kim3,4, Ximena Barros-Álvarez5, Ramona M Rodriguiz6,7, Ying Yang1, Oh Sang Kweon2, Tao Che8, John D McCorvy9, David N Kamber2, James P Phelan2, Luan Carvalho Martins1,10, Vladimir M Pogorelov6, Jeffrey F DiBerto3, Samuel T Slocum3, Xi-Ping Huang11, Jain Manish Kumar3, Michael J Robertson5, Ouliana Panova5, Alpay B Seven5, Autumn Q Wetsel6, William C Wetsel12,13,14,15, John J Irwin16, Georgios Skiniotis17, Brian K Shoichet18, Bryan L Roth19,20, Jonathan A Ellman21.   

Abstract

There is considerable interest in screening ultralarge chemical libraries for ligand discovery, both empirically and computationally1-4. Efforts have focused on readily synthesizable molecules, inevitably leaving many chemotypes unexplored. Here we investigate structure-based docking of a bespoke virtual library of tetrahydropyridines-a scaffold that is poorly sampled by a general billion-molecule virtual library but is well suited to many aminergic G-protein-coupled receptors. Using three inputs, each with diverse available derivatives, a one pot C-H alkenylation, electrocyclization and reduction provides the tetrahydropyridine core with up to six sites of derivatization5-7. Docking a virtual library of 75 million tetrahydropyridines against a model of the serotonin 5-HT2A receptor (5-HT2AR) led to the synthesis and testing of 17 initial molecules. Four of these molecules had low-micromolar activities against either the 5-HT2A or the 5-HT2B receptors. Structure-based optimization led to the 5-HT2AR agonists (R)-69 and (R)-70, with half-maximal effective concentration values of 41 nM and 110 nM, respectively, and unusual signalling kinetics that differ from psychedelic 5-HT2AR agonists. Cryo-electron microscopy structural analysis confirmed the predicted binding mode to 5-HT2AR. The favourable physical properties of these new agonists conferred high brain permeability, enabling mouse behavioural assays. Notably, neither had psychedelic activity, in contrast to classic 5-HT2AR agonists, whereas both had potent antidepressant activity in mouse models and had the same efficacy as antidepressants such as fluoxetine at as low as 1/40th of the dose. Prospects for using bespoke virtual libraries to sample pharmacologically relevant chemical space will be considered.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 36171289     DOI: 10.1038/s41586-022-05258-z

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   69.504


  59 in total

1.  Is there a difference between leads and drugs? A historical perspective.

Authors:  T I Oprea; A M Davis; S J Teague; P D Leeson
Journal:  J Chem Inf Comput Sci       Date:  2001 Sep-Oct

2.  Bigger is better in virtual drug screens.

Authors:  David E Gloriam
Journal:  Nature       Date:  2019-02       Impact factor: 49.962

Review 3.  Expanding the medicinal chemistry synthetic toolbox.

Authors:  Jonas Boström; Dean G Brown; Robert J Young; György M Keserü
Journal:  Nat Rev Drug Discov       Date:  2018-08-24       Impact factor: 84.694

4.  Structure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor.

Authors:  Kuglae Kim; Tao Che; Ouliana Panova; Jeffrey F DiBerto; Jiankun Lyu; Brian E Krumm; Daniel Wacker; Michael J Robertson; Alpay B Seven; David E Nichols; Brian K Shoichet; Georgios Skiniotis; Bryan L Roth
Journal:  Cell       Date:  2020-09-17       Impact factor: 41.582

5.  Escape from flatland: increasing saturation as an approach to improving clinical success.

Authors:  Frank Lovering; Jack Bikker; Christine Humblet
Journal:  J Med Chem       Date:  2009-11-12       Impact factor: 7.446

6.  Proton donor acidity controls selectivity in nonaromatic nitrogen heterocycle synthesis.

Authors:  Simon Duttwyler; Shuming Chen; Michael K Takase; Kenneth B Wiberg; Robert G Bergman; Jonathan A Ellman
Journal:  Science       Date:  2013-02-08       Impact factor: 47.728

7.  ZINC 15--Ligand Discovery for Everyone.

Authors:  Teague Sterling; John J Irwin
Journal:  J Chem Inf Model       Date:  2015-11-09       Impact factor: 4.956

8.  Ultra-large library docking for discovering new chemotypes.

Authors:  Jiankun Lyu; Sheng Wang; Trent E Balius; Isha Singh; Anat Levit; Yurii S Moroz; Matthew J O'Meara; Tao Che; Enkhjargal Algaa; Kateryna Tolmachova; Andrey A Tolmachev; Brian K Shoichet; Bryan L Roth; John J Irwin
Journal:  Nature       Date:  2019-02-06       Impact factor: 49.962

9.  Virtual discovery of melatonin receptor ligands to modulate circadian rhythms.

Authors:  Reed M Stein; Hye Jin Kang; John D McCorvy; Grant C Glatfelter; Anthony J Jones; Tao Che; Samuel Slocum; Xi-Ping Huang; Olena Savych; Yurii S Moroz; Benjamin Stauch; Linda C Johansson; Vadim Cherezov; Terry Kenakin; John J Irwin; Brian K Shoichet; Bryan L Roth; Margarita L Dubocovich
Journal:  Nature       Date:  2020-02-10       Impact factor: 49.962

10.  An open-source drug discovery platform enables ultra-large virtual screens.

Authors:  Andras Boeszoermenyi; Zi-Fu Wang; Christoph Gorgulla; Patrick D Fischer; Paul W Coote; Krishna M Padmanabha Das; Yehor S Malets; Dmytro S Radchenko; Yurii S Moroz; David A Scott; Konstantin Fackeldey; Moritz Hoffmann; Iryna Iavniuk; Gerhard Wagner; Haribabu Arthanari
Journal:  Nature       Date:  2020-03-09       Impact factor: 49.962

View more
  1 in total

1.  Taking the tripping out of psychedelic medicine.

Authors:  Elie Dolgin
Journal:  Nature       Date:  2022-09       Impact factor: 69.504

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.